Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006
- PMID: 21553664
- PMCID: PMC3072857
- DOI: 10.1177/003335491112600309
Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006
Abstract
Objectives: Antibiotic resistance is a significant global problem, but the trends in prevalence and impact of antibiotic resistance in hospitalizations in the United States are unclear. We evaluated the trends in hospitalizations associated with antibiotic-resistant infections in U.S. hospitals from 1997 to 2006.
Methods: We analyzed the National Hospital Discharge Survey (NHDS) during 1997-2006 (unweighted n = 3.3 million hospitalizations; weighted n = 370.3 million hospitalizations) and examined trends in prevalence of hospitalizations with antibiotic-resistant infections, length of stay, and discharge status.
Results: The number of infection-related hospitalizations with antibiotic resistance increased 359% during the 10-year period, from 37,005 in 1997 to 169,985 in 2006. The steepest rise was seen among individuals < 18 years of age. The mean age of individuals with infection-related hospitalizations that had antibiotic-resistant infections decreased substantially, from 65.7 years (standard error [SE] = 2.01) in 1997 to 44.2 years (SE = 1.47) in 2006. As the proportion of patients with antibiotic-resistant infections who did not have insurance increased, the length of stay for those hospitalizations had a corresponding decrease (r = 0.91, p < 0.01).
Conclusions: Antibiotic-resistant infections are becoming increasingly commonplace in hospitalizations in the U.S., with a steady upward trend between 1997 and 2006. Antibiotic-resistant infections are increasingly being seen in younger patients and those without health insurance.
Figures



Similar articles
-
Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals : Retrospective Cohort Study of Trends and Risk Factors.Ann Intern Med. 2025 Jun;178(6):796-807. doi: 10.7326/ANNALS-24-03078. Epub 2025 Apr 29. Ann Intern Med. 2025. PMID: 40294418
-
Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.Infect Control Hosp Epidemiol. 2009 Feb;30(2):184-6. doi: 10.1086/593956. Infect Control Hosp Epidemiol. 2009. PMID: 19125679
-
Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.Infect Control Hosp Epidemiol. 2013 Sep;34(9):940-6. doi: 10.1086/671740. Epub 2013 Jul 25. Infect Control Hosp Epidemiol. 2013. PMID: 23917908
-
Overview: Global and Local Impact of Antibiotic Resistance.Infect Dis Clin North Am. 2016 Jun;30(2):313-322. doi: 10.1016/j.idc.2016.02.001. Infect Dis Clin North Am. 2016. PMID: 27208761 Review.
-
Antimicrobial resistance among pathogenic bacteria in Southeast Asia.Southeast Asian J Trop Med Public Health. 2012 Mar;43(2):385-422. Southeast Asian J Trop Med Public Health. 2012. PMID: 23082591 Review.
Cited by
-
Occupational exposure to Staphylococcus aureus and Enterococcus spp. among spray irrigation workers using reclaimed water.Int J Environ Res Public Health. 2014 Apr 17;11(4):4340-55. doi: 10.3390/ijerph110404340. Int J Environ Res Public Health. 2014. PMID: 24747541 Free PMC article.
-
Trends and impact of antimicrobial resistance on older inpatients with urinary tract infections (UTIs): A national retrospective observational study.PLoS One. 2019 Oct 3;14(10):e0223409. doi: 10.1371/journal.pone.0223409. eCollection 2019. PLoS One. 2019. PMID: 31581222 Free PMC article.
-
Chemical Synthesis of Innovative Silver Nanohybrids with Synergistically Improved Antimicrobial Properties.Int J Nanomedicine. 2023 May 3;18:2295-2305. doi: 10.2147/IJN.S405255. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37163141 Free PMC article.
-
Transferrin saturation and hospital length of stay and mortality in Medicare beneficiaries.J Am Geriatr Soc. 2013 Jan;61(1):132-6. doi: 10.1111/jgs.12044. Epub 2012 Dec 3. J Am Geriatr Soc. 2013. PMID: 23205743 Free PMC article.
-
The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate.Health Serv Res. 2019 Aug;54(4):782-792. doi: 10.1111/1475-6773.13135. Epub 2019 Mar 12. Health Serv Res. 2019. PMID: 30864179 Free PMC article.
References
-
- Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Sheld WM, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Disease Society of America. Clin Infect Dis. 2008;46:155–64. - PubMed
-
- Smolinski MS, Hamburg MA, Lederberg J, editors. Microbial threats to health: emergence, detection, and response. Washington: Institute of Medicine; 2003. - PubMed
-
- Infectious Diseases Society of America. Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. Alexandria (VA): Infectious Diseases Society of America; 2004.
-
- Wang SA, Harvey AB, Conner SM, Zaidi AA, Knapp JS, Whittington WL, et al. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med. 2007;147:81–8. - PubMed
-
- Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Stevenson J, et al. Typhoid fever in the United States, 1999–2006. JAMA. 2009;302:859–65. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials